socalTECH

JANUARY 27, 2021

San Diego-based Design Therapeutics, a biotech company which is developing small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, said it has raised $125M in its Series B funding round. Rowe Price Associates, Inc., Arsani William, M.D.,

Design 113

Design San Diego Capital Pricing 113

socalTECH

OCTOBER 28, 2020

San Diego-based Arena Pharmaceuticals announced this morning that it has launched a new company, Longboard Pharmaceuticals , with $56M in funding. The new funding comes from Farallon Capital, Cormorant Asset Management, HBM Healthcare Investments, Highside Capital Management, and T.

Funding 113

Funding San Diego Pricing Capital 113

socalTECH

SEPTEMBER 23, 2019

A portfolio company of San Diego-based biopharmaceuticals venture investor Versant Ventures is getting set for its IPO this week. Aprea Therapeutics said that estimates its IPO will price between $14.00 Aprea's investment bankers on the IPO are J.P. and $16.00 per share, which could raise as much as $92.0M READ MORE>>.

San Diego 113

San Diego Pricing Invest Marketing 113

socalTECH

SEPTEMBER 29, 2020

San Diego-based Seismic , which develops sales enablement and marketing software, has joined the unicorn club, saying this morning that it has raised $92M in a Series F funding, which values the company at approximately $1.6 Rowe Price, its existing investors. Seismic has now raised a total of $270M in funding.

San Diego 113

San Diego Sales Pricing Activity 113

Xconomy

FEBRUARY 1, 2019

Pharmaceutical companies typically raise prescription drug prices at the start of each year and this year was no different. The increases were the latest reminder that, despite President Trump’s fiery campaign rhetoric, the administration had done little to actually lower drug prices.

Pricing 84

Pricing Services Company Companies 84

socalTECH

AUGUST 29, 2018

San Diego-based Obalon Therapeutics , a publicly held developer of medical devices to treat obesity, has raised $10M in a private placement, the company said this week. The company said it 5,494,506 shares of common stock at a price of $1.82 per share in the offering. Obalon trades on the NASDAQ as OBLN. READ MORE>>.

San Diego 100

San Diego Pricing Invest Funding 100

socalTECH

OCTOBER 10, 2019

San Diego-based Mercato , which provides delivery of items from independently owned grocery and specialty food stores, has launched a new program that offers up unlimited free, same-day grocery delivery from local grocery stores. Mercato is led by founder and CEO Bobby Brannigan. Mercato is led by founder and CEO Bobby Brannigan.

San Diego 113

San Diego Pricing Funding Invest 113

socalTECH

JUNE 29, 2012

San Diego-based ServiceNow has proven that the market for initial public offerings is still strong this morning, opening up at $23.08 The firm priced its IPO above estimates, at $18.00 The firm had earlier estimated an initial pricing range of $15.00 JMI Equity is based in San Diego. READ MORE>>.

San Diego 176

San Diego Equity Pricing Invest 176

Xconomy

OCTOBER 27, 2016

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says.

Venture Capital 40

Venture Capital Pricing Invest Report 40

TechCrunch LA

FEBRUARY 6, 2022

The Facebook parent-company saw its stock price get bludgeoned after a bad earnings report showcased that Apple’s ad-blocking changes are shaving billions off its books and the company’s crown jewel — the Facebook platform — has stopped growing and actually shrank this quarter. . Image Credits: Facebook.

Marketing 246

Marketing Newsletter Technical Review News 246

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

FEBRUARY 9, 2016

Orange County-based KGrid , a cleantech startup working on electric car charging stations, said it has received an investment from German utility RWE , via RWE New Ventures LLC. Financial terms of the investment were not announced. KnGrid was founded by Stephen G. Davis and David Hawkins. READ MORE>>.

Orange County 100

Orange County Funding San Diego Pricing 100

TechCrunch LA

MARCH 20, 2019

The feature illustrates how Postmates, one of the earlier entrants to the billion-dollar food delivery wars , is trying to remain competitive by appealing to price-sensitive customers. Los Angeles, Miami, New York City, Phoenix, San Francisco, San Diego, Seattle, Orange County, Calif. and Philadelphia. billion valuation.

Orange County 200

Orange County Long Beach San Diego Los Angeles 200

socalTECH

MAY 7, 2015

San Diego-based biotech developer aTyr Pharma is debuting in its IPO this morning, after pricing its IPO at $14.00 aTyr Pharma was venture backed by Fidelity Investments, Domain Associate, Polaris Partners, Alta Partners, Cardinal Partners, Sofinnova Ventures, and others. per share last night.

San Diego 100

San Diego Pricing Invest Marketing 100

Xconomy

JULY 13, 2018

Drug price changes typically happen either at the start of the calendar year or the beginning of the third quarter. Such changes are routine for many companies, but Pfizer took an unusual step this week by rolling back scheduled price increases on 40 of its drugs. In May, Trump and. Read more » Reprints | Share:

Pricing 56

Pricing Guide News Services 56

Xconomy

JULY 29, 2020

On Wednesday the Cambridge, MA-based company, which was launched last year by Third Rock Ventures, announced that New York investment firm Casdin Capital and San Diego area-based venture firm Section 32 had co-led its Series B. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 87

San Diego Study Capital Invest 87

Xconomy

JANUARY 10, 2020

Signatories agreed to what they dubbed a New Commitment to Patients, a list of “core principals and actions” promising that “pricing of our medicines at launch will reflect innovation and value to patients” and “any price increases on our medicines must be reasonable and guided by the need for uninterrupted patient access.”

Pricing 52

Pricing Guide San Diego Company 52

Xconomy

DECEMBER 18, 2018

The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Thompson to its board of directors. In Southern California, rounds that large are more often raised by life sciences companies.)

Southern California 110

Southern California San Diego Software Invest 110

socalTECH

JANUARY 20, 2015

San Diego-based biopharmaceuticals developer Tracon Pharmaceuticals said in a regulatory filing today that it is estimated its IPO pricing at between $12.00 The companyis venture backed by JAFCO Ventures, New Enterprise Associates, Brookline Investments, Nextech Oncology, BioMed Ventures, along with others. and $14.00

San Diego 100

San Diego Acquisition Pricing Invest 100

Xconomy

JANUARY 11, 2017

The firm acknowledged price hikes on several drugs that stayed—sometimes barely—under the 10 percent limit that CEO Brent Saunders pledged last September, in what he called a “ social contract with patients.” The first test of pharmaceutical giant Allergan’s promise to behave responsibly came last week.

Pricing 40

Pricing .Net Conference Invest 40

socalTECH

OCTOBER 3, 2012

Prolific San Diego angel investor Howard Lindzon , who runs StockTwits , has scored a big exit at one of his portfolio companies, LifeLock , after the firm had its IPO this morning. Lindzon said it was an early angel investor in the company, and made his investment in 2006 at "well under a $10M valuation". and $11.50

Symantec 133

Symantec San Diego Pricing Invest 133

socalTECH

OCTOBER 31, 2012

San Diego-based ServiceNow is looking to sell $300M in a secondary IPO offering, according to a filing made by the company Wednesday. ServiceNow went public in June, pricing at $18.00 The firm said it will not receive any proceeds from the sale by the selling stockholders. per share; the firm is now trading around $30.65

San Diego 138

San Diego Equity Pricing Sales 138

TechCrunch LA

DECEMBER 8, 2020

He did note that in the four markets where the company has gone live since launching its business in January 2019 — San Diego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).

Sales 282

Sales Demand San Diego Funding 282

Xconomy

OCTOBER 26, 2018

In the biotech investment and research communities this week, much of the attention was turned to Europe.

Pricing 86

Pricing Conference Research Invest 86

Xconomy

JULY 14, 2017

Akcea Therapeutics is joining the parade of biotechs going public, but the company had to cut its stock price and sell more shares in order to pull it off. But the biotech priced its offering of 15.6 Cambridge, MA-based Akcea had planned on raising $125 million from the initial public offering, and it hit that target.

Pricing 57

Pricing Company Companies San Diego 57

Xconomy

APRIL 13, 2017

San Diego-based Tocagen (NASDAQ: TOCA ) priced its offering of 8.5 million shares priced between $10 to $12 each. Tocagen raised $85 million in its stock market debut today, and underwriters saw enough demand to increase the number of shares in the initial public offering. million shares at $10 per share.

San Diego 66

San Diego Pricing Demand Marketing 66

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

socalTECH

JUNE 30, 2010

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. The firm was advised by Peter J. Solomon Company in the deal.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140

Xconomy

NOVEMBER 20, 2019

Drug pricing debates and uncertainty associated with Brexit are the issues most likely to keep biopharmaceutical executives awake at night. These are among the major findings of a survey of 500 industry leaders and investors conducted by investment bank Jefferies. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 78

Pricing Invest Develop Development 78

Xconomy

JANUARY 29, 2019

The New York-based startup said Tuesday that the new funding round, which is being led by Goldman Sachs Private Capital Investing group, brings its total investment to $35 million. Billie, a monthly subscription service for shaving and body care products for women, has raised $25 million.

Product 90

Product Services Invest Pricing 90

socalTECH

JUNE 7, 2011

San Diego-based StockTwits , the real-time messaging service focused on the stock investing community led by Howard Lindzon, is aiming at the investors relation community with a new service. In particular, StockTwits has addressed some of the compliance concerns of public companies.

San Diego 140

San Diego News Pricing Ideas 140

SoCal Tech Calendar

MAY 27, 2011

San Diego Tech Coast Angeles. Early Exits describes a strategy for startup investors and entrepreneurs to build a new ventures, prove business models and exit companies in 2-3 years without the need for multi-million dollar investments. Thursday, June 2, 2011 -- Early Exits.

Tech Coast Angels 100

Tech Coast Angels Venture Capital San Diego Pricing 100

Xconomy

DECEMBER 22, 2016

Although the venture capital path is always a possibility, founders are often concerned about the consequences of such investments.

Pricing 40

Pricing Venture Capital Capital Networking 40

Xconomy

JULY 19, 2019

Soaring prices of Bitcoin and other so-called digital tokens were attracting investments from speculators hoping to get rich quick—but these virtual coin values were also known to drop just as suddenly, the US Treasury Department’s Financial Stability Oversight Council noted.

Pricing 89

Pricing Report Invest Venture Capital 89

Xconomy

JUNE 3, 2019

Viking’s investment was a note that will convert into the company’s common stock after the initial public offering at a discount—equal to 90 percent of the price per share of the. Read more about the company’s history and its recent $40 million financing round hedge fund Viking Global Investors here.

Funding 79

Funding Pricing Invest Develop 79

Xconomy

DECEMBER 14, 2018

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. to offer competitive pricing pressure.

Patents 77

Patents Pricing Competition San Diego 77

Xconomy

DECEMBER 13, 2019

If you’re keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there’s Sarepta Therapeutics. Late Thursday, the FDA announced approval of the Cambridge, MA, biotech’s drug for Duchenne muscular dystrophy in patients who have a specific mutation.

Pricing 49

Pricing Southern California USC San Diego 49